Search results
Results from the WOW.Com Content Network
Novo Nordisk is the largest pharmaceutical company in Denmark. [14] Novo Nordisk's market capitalization exceeded the GDP of Denmark's domestic economy in 2023, and it is the highest valued company in Europe. [15] Revenue in 2023 was 33.724 billion USD.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Revenue (billions US$) Profit (billions US$) Assets (billions US$) Value (billions US$) Industry 1 262 Maersk Group: Copenhagen 39.0 3.1 56.6 28.1 Transportation 2 339 Danske Bank: Copenhagen 15.4 2.2 548.2 16.6 Banking: 3 376 Novo Nordisk: Bagsværd: 17.7 6.1 17.0 116.3 Pharmaceuticals: 4 486 Ørsted: Copenhagen 11.5 2.8 26.7 31.4 Utilities: 5 ...
Danish pharmaceutical company Novo Nordisk (NYSE: NVO) is pioneering a new wave of medical treatment for diabetes and obesity care.. The company develops a long line of blockbuster glucagon-like ...
Valo is also eligible to receive milestone payments for up to 11 programmes, totalling up to $2.7 billion, plus research and d ... Novo Nordisk said in a statement it will use Valo's platform and ...
For premium support please call: 800-290-4726 more ways to reach us
Novo Holdings A/S (formerly Novo A/S) [1] is the Novo Nordisk Foundation's wholly owned holding company for Novo Nordisk A/S and Novozymes A/S. Novo Holdings A/S was established in 1999 and manages the Novo Nordisk Foundation 's assets, which in 2023 was worth almost DKK 1,114 billion [ 2 ] [ 3 ] [ 4 ] Danish Kroner (approximately US$163 billion).
The Novo Nordisk Foundation didn't return Yahoo Finance's request to be interviewed for this story. Allie Garfinkle is a Senior Tech Reporter at Yahoo Finance. Follow her on X, formerly Twitter ...